You searched for metabolic diseases - Page 13 of 64

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

…adding that future pioneers could “completely upend the way we are doing things.” Picture/Shutterstock From rare diseases to bigger indications One reason that gene editing companies treat rare diseases is…

November 3, 2022 - 8 minutesmins - By Jonathan Smith

News and Trends 8 Jun 2023

Kate Therapeutics launches with $51M to develop genetic medicines for muscle and heart diseases

…worldwide license to develop, manufacture and commercialize KT430 to treat X-linked myotubular myopathy (XLMTM). There are a large number of genetically defined and complex muscle and heart diseases that cannot…

June 8, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop and commercialize innovative treatments for respiratory diseases using Affibody’s proprietary technology. Under the terms of…

March 8, 2023 - 3 minutesmins - By Jim Cornall

Startup Scout 1 Feb 2019

This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo

…diseases. Mission: To rapidly screen thousands of stool samples from a Norwegian population study and link the gut microbiome with disease. Client companies will then be able to pay Bio-Me…

February 1, 2019 - 4 minutesmins - By Jonathan Smith

som biotech huntingtons disease repurpose amyloidosis

Startup Scout 29 Mar 2019

This Biotech Repurposes Drugs to Fight Huntington’s Disease

Barcelona-based SOM Biotech is developing treatments for incurable diseases such as Huntington’s disease with drugs that are already on the market for other diseases. Mission: To repurpose commercially available drugs…

March 29, 2019 - 4 minutesmins - By Jonathan Smith

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

Human Immunology Biosciences (HI-Bio), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced its launch with $120 million in financing. HI-Bio was incubated by…

November 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 3 Aug 2022

Chinese biotech Sironax closes $200M funding round

…multiple programs with a focus on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways and neuroinflammation. Age-related degenerative diseases Sironax plans to use the proceeds to…

August 3, 2022 - 3 minutesmins - By Jim Cornall

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

…limited and currently lacking cures. However, because of the rarity of such diseases, the market potential of orphan vaccines developed to tackle orphan diseases may not always offset development costs….

November 3, 2022 - 8 minutesmins - By Sudha Sundaram

News and Trends 3 Aug 2022

Full label approval given by FDA for eye disease drug, CIMERLI

…decades, the burden of diabetic-related eye diseases, like DME and DR, are also likely to rise. As the prevalence of serious retinal diseases increases, so do the costs of treating…

August 3, 2022 - 4 minutesmins - By Liza Laws

News and Trends 29 Nov 2016

New British Partnership set to Cure Rare Diseases with Gene Therapy

Oxford BioMedica and Orchard Therapeutics are partnering up to bring gene therapy to the market and treat rare diseases for which no cure is available yet. Oxford BioMedica develops lentiviral…

November 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Apr 2023

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

…advanced glycation end products (RAGE) as a potential treatment for inflammatory pulmonary diseases, such as asthma. These data represent the first clinical demonstration of the potential utility of Arrowhead Pharmaceuticals’…

April 27, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 27 Feb 2025

Eight respiratory disease companies advancing innovative therapies in 2025

…diseases – one for inflammatory pulmonary diseases and one for idiopathic pulmonary fibrosis. The inflammatory pulmonary disease candidate is called ARO-RAGE. It is an RNAi therapeutic targeting the receptor for…

February 27, 2025 - 12 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

What’s on the horizon for gene editing-based therapies?

Kate Therapeutics launches with $51M to develop genetic medicines for muscle and heart diseases

Affibody and Chiesi Group to develop treatments for respiratory diseases

This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo

This Biotech Repurposes Drugs to Fight Huntington’s Disease

Human Immunology Biosciences launches with $120M

Chinese biotech Sironax closes $200M funding round

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

Full label approval given by FDA for eye disease drug, CIMERLI

New British Partnership set to Cure Rare Diseases with Gene Therapy

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

Eight respiratory disease companies advancing innovative therapies in 2025

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!